Skip to main content
. 2018 Oct 1;53(6):2397–2408. doi: 10.3892/ijo.2018.4579

Table II.

Relative expression of CD147 and IGFBP2 in PMM and MMM.

A, CD147 expression

Tumor type Cases Weak Moderate Strong Positive rate (%)
PMM 128 28 68 32 78.1
MMM 64 4 11 49 93.8a
B, IGFBP2 expression

Tumor type Cases Weak Moderate Strong Positive rate (%)
PMM 128 25 75 28 80.5
MMM 64 6 18 40 90.6a
a

P<0.05 vs. PMM. CD, cluster of differentiation; IGFBP2, insulin-like growth factor-binding protein 2; PMM, primary malignant melanoma; MMM, metastatic malignant melanoma.